FARALLON CAPITAL MANAGEMENT, L.L.C. Diversified Active

Location: San Francisco, CA

CIK: 0000909661 · Show all filings

Period: Q4 2019 (← Previous) (Next →)

Filing Date: May 15, 2020

Total Value: $14.82B

Holdings (116)

— ALLERGAN PLC 10.3%
Value $1.527B Shares 7,990,000 Share Price $191.17 Est. Cost/Share — Unrealized @ Report Date —
SPY SPDR S&P 500 ETF TR 9.5%
Value $1.411B Shares 4,385,000 Share Price $321.86 Est. Cost/Share — Unrealized @ Report Date —
— WELLCARE HEALTH PLANS INC 5.3%
Value $793M Shares 2,400,000 Share Price $330.21 Est. Cost/Share — Unrealized @ Report Date —
— IAC INTERACTIVECORP 3.5%
Value $515M Shares 2,066,500 Share Price $249.11 Est. Cost/Share — Unrealized @ Report Date —
FIS FIDELITY NATL INFORMATION SV 3.3%
Value $485M Shares 3,485,757 Share Price $139.09 Est. Cost/Share — Unrealized @ Report Date —
WAB WABTEC CORP 2.7%
Value $394M Shares 5,069,187 Share Price $77.80 Est. Cost/Share — Unrealized @ Report Date —
ELV ANTHEM INC 2.5%
Value $378M Shares 1,250,000 Share Price $302.03 Est. Cost/Share — Unrealized @ Report Date —
GOOG ALPHABET INC 2.5%
Value $368M Shares 274,903 Share Price $1337.02 Est. Cost/Share — Unrealized @ Report Date —
SMH VANECK VECTORS ETF TRUST 2.4%
Value $354M Shares 2,505,000 Share Price $141.41 Est. Cost/Share — Unrealized @ Report Date —
MSFT MICROSOFT CORP 2.3%
Value $345M Shares 2,185,790 Share Price $157.70 Est. Cost/Share — Unrealized @ Report Date —
CHTR CHARTER COMMUNICATIONS INC N 2.2%
Value $331M Shares 683,093 Share Price $485.08 Est. Cost/Share — Unrealized @ Report Date —
CI CIGNA CORP NEW 2.1%
Value $307M Shares 1,500,000 Share Price $204.49 Est. Cost/Share — Unrealized @ Report Date —
IQV IQVIA HLDGS INC 1.9%
Value $287M Shares 1,854,687 Share Price $154.51 Est. Cost/Share — Unrealized @ Report Date —
V VISA INC 1.9%
Value $286M Shares 1,522,460 Share Price $187.90 Est. Cost/Share — Unrealized @ Report Date —
— MEDICINES CO 1.9%
Value $282M Shares 3,315,000 Share Price $84.94 Est. Cost/Share — Unrealized @ Report Date —
CRM SALESFORCE COM INC 1.9%
Value $281M Shares 1,724,880 Share Price $162.64 Est. Cost/Share — Unrealized @ Report Date —
TMO THERMO FISHER SCIENTIFIC INC 1.9%
Value $277M Shares 853,160 Share Price $324.87 Est. Cost/Share — Unrealized @ Report Date —
— PLAYA HOTELS & RESORTS NV 1.7%
Value $257M Shares 30,606,930 Share Price $8.40 Est. Cost/Share — Unrealized @ Report Date —
PANW PALO ALTO NETWORKS INC 1.7%
Value $256M Shares 1,108,416 Share Price $231.25 Est. Cost/Share — Unrealized @ Report Date —
EQIX EQUINIX INC 1.6%
Value $243M Shares 416,323 Share Price $583.70 Est. Cost/Share — Unrealized @ Report Date —
BABA ALIBABA GROUP HLDG LTD 1.6%
Value $240M Shares 1,132,500 Share Price $212.10 Est. Cost/Share — Unrealized @ Report Date —
— ZAYO GROUP HLDGS INC 1.6%
Value $236M Shares 6,820,000 Share Price $34.65 Est. Cost/Share — Unrealized @ Report Date —
ABBV ABBVIE INC 1.5%
Value $221M Shares 2,500,000 Share Price $88.54 Est. Cost/Share — Unrealized @ Report Date —
SHW SHERWIN WILLIAMS CO 1.4%
Value $215M Shares 367,775 Share Price $583.54 Est. Cost/Share — Unrealized @ Report Date —
META FACEBOOK INC 1.4%
Value $211M Shares 1,030,313 Share Price $205.25 Est. Cost/Share — Unrealized @ Report Date —
— IHS MARKIT LTD 1.4%
Value $207M Shares 2,743,550 Share Price $75.35 Est. Cost/Share — Unrealized @ Report Date —
ASND ASCENDIS PHARMA A S 1.2%
Value $178M Shares 1,279,000 Share Price $139.12 Est. Cost/Share — Unrealized @ Report Date —
SPGI S&P GLOBAL INC 1.2%
Value $175M Shares 640,382 Share Price $273.05 Est. Cost/Share — Unrealized @ Report Date —
GD GENERAL DYNAMICS CORP 1.2%
Value $173M Shares 981,365 Share Price $176.35 Est. Cost/Share — Unrealized @ Report Date —
IOVA IOVANCE BIOTHERAPEUTICS INC 1.2%
Value $173M Shares 6,250,000 Share Price $27.68 Est. Cost/Share — Unrealized @ Report Date —
ALNY ALNYLAM PHARMACEUTICALS INC 1.1%
Value $167M Shares 1,450,000 Share Price $115.17 Est. Cost/Share — Unrealized @ Report Date —
— MYOKARDIA INC 1.0%
Value $149M Shares 2,050,000 Share Price $72.88 Est. Cost/Share — Unrealized @ Report Date —
EXEL EXELIXIS INC 0.9%
Value $132M Shares 7,500,000 Share Price $17.62 Est. Cost/Share — Unrealized @ Report Date —
TRU TRANSUNION 0.9%
Value $131M Shares 1,527,771 Share Price $85.61 Est. Cost/Share — Unrealized @ Report Date —
ENTA ENANTA PHARMACEUTICALS INC 0.7%
Value $108M Shares 1,750,000 Share Price $61.78 Est. Cost/Share — Unrealized @ Report Date —
— ACCELERON PHARMA INC 0.7%
Value $106M Shares 2,000,000 Share Price $53.02 Est. Cost/Share — Unrealized @ Report Date —
— BROADMARK RLTY CAP INC 0.6%
Value $91.48M Shares 7,174,613 Share Price $12.75 Est. Cost/Share — Unrealized @ Report Date —
— BRISTOL MYERS SQUIBB CO 0.6%
Value $91.43M Shares 30,374,950 Share Price $3.01 Est. Cost/Share — Unrealized @ Report Date —
EFX EQUIFAX INC 0.6%
Value $91.39M Shares 652,189 Share Price $140.12 Est. Cost/Share — Unrealized @ Report Date —
— ZOGENIX INC 0.6%
Value $91.23M Shares 1,750,000 Share Price $52.13 Est. Cost/Share — Unrealized @ Report Date —
— AMARIN CORP PLC 0.6%
Value $88.44M Shares 4,125,000 Share Price $21.44 Est. Cost/Share — Unrealized @ Report Date —
— ANIXTER INTL INC 0.6%
Value $84.54M Shares 917,893 Share Price $92.10 Est. Cost/Share — Unrealized @ Report Date —
— ZYMEWORKS INC 0.5%
Value $77.28M Shares 1,700,000 Share Price $45.46 Est. Cost/Share — Unrealized @ Report Date —
— QIAGEN NV 0.5%
Value $72.81M Shares 2,154,000 Share Price $33.80 Est. Cost/Share — Unrealized @ Report Date —
GRFS GRIFOLS S A 0.5%
Value $72.51M Shares 3,113,222 Share Price $23.29 Est. Cost/Share — Unrealized @ Report Date —
— AUDENTES THERAPEUTICS INC 0.5%
Value $71.21M Shares 1,190,000 Share Price $59.84 Est. Cost/Share — Unrealized @ Report Date —
AGIO AGIOS PHARMACEUTICALS INC 0.4%
Value $59.69M Shares 1,250,000 Share Price $47.75 Est. Cost/Share — Unrealized @ Report Date —
— GLOBAL BLOOD THERAPEUTICS IN 0.4%
Value $59.62M Shares 750,000 Share Price $79.49 Est. Cost/Share — Unrealized @ Report Date —
— CHEMOCENTRYX INC 0.4%
Value $59.33M Shares 1,500,000 Share Price $39.55 Est. Cost/Share — Unrealized @ Report Date —
— DECIPHERA PHARMACEUTICALS IN 0.4%
Value $59.13M Shares 950,000 Share Price $62.24 Est. Cost/Share — Unrealized @ Report Date —
— FIBROGEN INC 0.4%
Value $57.9M Shares 1,350,000 Share Price $42.89 Est. Cost/Share — Unrealized @ Report Date —
— RA PHARMACEUTICALS INC 0.4%
Value $55.76M Shares 1,188,100 Share Price $46.93 Est. Cost/Share — Unrealized @ Report Date —
CVS CVS HEALTH CORP 0.4%
Value $55.72M Shares 750,000 Share Price $74.29 Est. Cost/Share — Unrealized @ Report Date —
— MOMENTA PHARMACEUTICALS INC 0.4%
Value $54.26M Shares 2,750,000 Share Price $19.73 Est. Cost/Share — Unrealized @ Report Date —
SRPT SAREPTA THERAPEUTICS INC 0.3%
Value $51.62M Shares 400,000 Share Price $129.04 Est. Cost/Share — Unrealized @ Report Date —
— ARQULE INC 0.3%
Value $50.3M Shares 2,520,000 Share Price $19.96 Est. Cost/Share — Unrealized @ Report Date —
— PTC THERAPEUTICS INC 0.3%
Value $45.85M Shares 39,676,000 Share Price $1.16 Est. Cost/Share — Unrealized @ Report Date —
AXSM AXSOME THERAPEUTICS INC 0.3%
Value $45.71M Shares 442,222 Share Price $103.36 Est. Cost/Share — Unrealized @ Report Date —
— KARUNA THERAPEUTICS INC 0.3%
Value $45.2M Shares 600,000 Share Price $75.34 Est. Cost/Share — Unrealized @ Report Date —
FATE FATE THERAPEUTICS INC 0.3%
Value $44.03M Shares 2,250,000 Share Price $19.57 Est. Cost/Share — Unrealized @ Report Date —
— PROGENICS PHARMACEUTICALS IN 0.3%
Value $41.99M Shares 8,250,000 Share Price $5.09 Est. Cost/Share — Unrealized @ Report Date —
— RADIUS HEALTH INC 0.3%
Value $41.42M Shares 2,054,486 Share Price $20.16 Est. Cost/Share — Unrealized @ Report Date —
— TRICIDA INC 0.3%
Value $37.74M Shares 1,000,000 Share Price $37.74 Est. Cost/Share — Unrealized @ Report Date —
— CARA THERAPEUTICS INC 0.3%
Value $37.05M Shares 2,300,000 Share Price $16.11 Est. Cost/Share — Unrealized @ Report Date —
— SAGE THERAPEUTICS INC 0.2%
Value $36.09M Shares 500,000 Share Price $72.19 Est. Cost/Share — Unrealized @ Report Date —
PTCT PTC THERAPEUTICS INC 0.2%
Value $34.92M Shares 726,986 Share Price $48.03 Est. Cost/Share — Unrealized @ Report Date —
— KARYOPHARM THERAPEUTICS INC 0.2%
Value $34.43M Shares 24,000,000 Share Price $1.43 Est. Cost/Share — Unrealized @ Report Date —
— ZEALAND PHARMA A S 0.2%
Value $33.52M Shares 1,009,800 Share Price $33.20 Est. Cost/Share — Unrealized @ Report Date —
— CYPRESS SEMICONDUCTOR CORP 0.2%
Value $32.44M Shares 18,645,000 Share Price $1.74 Est. Cost/Share — Unrealized @ Report Date —
— MELLANOX TECHNOLOGIES LTD 0.2%
Value $31.64M Shares 270,000 Share Price $117.18 Est. Cost/Share — Unrealized @ Report Date —
— AVROBIO INC 0.2%
Value $31.2M Shares 1,550,000 Share Price $20.13 Est. Cost/Share — Unrealized @ Report Date —
— TIFFANY & CO NEW 0.2%
Value $30.07M Shares 225,000 Share Price $133.65 Est. Cost/Share — Unrealized @ Report Date —
— INSTRUCTURE INC 0.2%
Value $29.89M Shares 620,000 Share Price $48.21 Est. Cost/Share — Unrealized @ Report Date —
— INVITAE CORP 0.2%
Value $28.23M Shares 1,750,000 Share Price $16.13 Est. Cost/Share — Unrealized @ Report Date —
VCYT VERACYTE INC 0.2%
Value $27.92M Shares 1,000,000 Share Price $27.92 Est. Cost/Share — Unrealized @ Report Date —
— STEMLINE THERAPEUTICS INC 0.2%
Value $24.98M Shares 2,350,000 Share Price $10.63 Est. Cost/Share — Unrealized @ Report Date —
RC READY CAP CORP 0.2%
Value $24.94M Shares 1,617,170 Share Price $15.42 Est. Cost/Share — Unrealized @ Report Date —
— QUOTIENT LTD 0.2%
Value $23.77M Shares 2,500,000 Share Price $9.51 Est. Cost/Share — Unrealized @ Report Date —
— INTERCEPT PHARMACEUTICALS IN 0.2%
Value $23.15M Shares 17,500,000 Share Price $1.32 Est. Cost/Share — Unrealized @ Report Date —
— MIRATI THERAPEUTICS INC 0.2%
Value $22.55M Shares 175,000 Share Price $128.86 Est. Cost/Share — Unrealized @ Report Date —
— PRINCIPIA BIOPHARMA INC 0.1%
Value $21.91M Shares 400,000 Share Price $54.78 Est. Cost/Share — Unrealized @ Report Date —
SVRA SAVARA INC 0.1%
Value $21.62M Shares 4,825,086 Share Price $4.48 Est. Cost/Share — Unrealized @ Report Date —
— AMARIN CORP PLC 0.1%
Value $21.44M Shares 1,000,000 Share Price $21.44 Est. Cost/Share — Unrealized @ Report Date —
CRSP CRISPR THERAPEUTICS AG 0.1%
Value $21.32M Shares 350,000 Share Price $60.91 Est. Cost/Share — Unrealized @ Report Date —
— WRIGHT MED GROUP N V 0.1%
Value $21.03M Shares 690,000 Share Price $30.48 Est. Cost/Share — Unrealized @ Report Date —
HRTX HERON THERAPEUTICS INC 0.1%
Value $20.56M Shares 875,000 Share Price $23.50 Est. Cost/Share — Unrealized @ Report Date —
— CYPRESS SEMICONDUCTOR CORP 0.1%
Value $19.6M Shares 840,000 Share Price $23.33 Est. Cost/Share — Unrealized @ Report Date —
GEN NORTONLIFELOCK INC 0.1%
Value $18.37M Shares 720,000 Share Price $25.52 Est. Cost/Share — Unrealized @ Report Date —
— SPRINT CORPORATION 0.1%
Value $16.67M Shares 3,200,000 Share Price $5.21 Est. Cost/Share — Unrealized @ Report Date —
— EIGER BIOPHARMACEUTICALS INC 0.1%
Value $16.31M Shares 1,094,559 Share Price $14.90 Est. Cost/Share — Unrealized @ Report Date —
PACB PACIFIC BIOSCIENCES CALIF IN 0.1%
Value $15.42M Shares 3,000,000 Share Price $5.14 Est. Cost/Share — Unrealized @ Report Date —
— REATA PHARMACEUTICALS INC 0.1%
Value $15.33M Shares 75,000 Share Price $204.43 Est. Cost/Share — Unrealized @ Report Date —
APLS APELLIS PHARMACEUTICALS INC 0.1%
Value $15.31M Shares 500,000 Share Price $30.62 Est. Cost/Share — Unrealized @ Report Date —
— LIVONGO HEALTH INC 0.1%
Value $15.04M Shares 600,000 Share Price $25.06 Est. Cost/Share — Unrealized @ Report Date —
XGN EXAGEN INC 0.1%
Value $14.67M Shares 577,699 Share Price $25.40 Est. Cost/Share — Unrealized @ Report Date —
QURE UNIQURE NV 0.1%
Value $14.33M Shares 200,000 Share Price $71.66 Est. Cost/Share — Unrealized @ Report Date —
— CLOVIS ONCOLOGY INC 0.1%
Value $12.08M Shares 18,801,000 Share Price $0.64 Est. Cost/Share — Unrealized @ Report Date —
— LOGMEIN INC 0.1%
Value $11.17M Shares 130,241 Share Price $85.74 Est. Cost/Share — Unrealized @ Report Date —
PTGX PROTAGONIST THERAPEUTICS INC 0.1%
Value $10.57M Shares 1,500,000 Share Price $7.05 Est. Cost/Share — Unrealized @ Report Date —
— OPTINOSE INC 0.1%
Value $8.298M Shares 900,000 Share Price $9.22 Est. Cost/Share — Unrealized @ Report Date —
RCKT ROCKET PHARMACEUTICALS INC 0.1%
Value $8.059M Shares 354,082 Share Price $22.76 Est. Cost/Share — Unrealized @ Report Date —
— SANOFI 0.1%
Value $7.91M Shares 9,195,584 Share Price $0.86 Est. Cost/Share — Unrealized @ Report Date —
GOSS GOSSAMER BIO INC 0.1%
Value $7.815M Shares 500,000 Share Price $15.63 Est. Cost/Share — Unrealized @ Report Date —
DMTKQ DERMTECH INC 0.1%
Value $7.631M Shares 615,385 Share Price $12.40 Est. Cost/Share — Unrealized @ Report Date —
— ABEONA THERAPEUTICS INC 0.0%
Value $6.54M Shares 2,000,000 Share Price $3.27 Est. Cost/Share — Unrealized @ Report Date —
ARWR ARROWHEAD PHARMACEUTICALS IN 0.0%
Value $6.343M Shares 100,000 Share Price $63.43 Est. Cost/Share — Unrealized @ Report Date —
— PHASEBIO PHARMACEUTICALS INC 0.0%
Value $6.11M Shares 1,000,000 Share Price $6.11 Est. Cost/Share — Unrealized @ Report Date —
— RADIUS HEALTH INC 0.0%
Value $5.787M Shares 6,750,000 Share Price $0.86 Est. Cost/Share — Unrealized @ Report Date —
— OYSTER POINT PHARMA INC 0.0%
Value $5.641M Shares 230,800 Share Price $24.44 Est. Cost/Share — Unrealized @ Report Date —
— ATARA BIOTHERAPEUTICS INC 0.0%
Value $5.513M Shares 334,706 Share Price $16.47 Est. Cost/Share — Unrealized @ Report Date —
XRX XEROX HOLDINGS CORP 0.0%
Value $4.793M Shares 130,000 Share Price $36.87 Est. Cost/Share — Unrealized @ Report Date —
OPK OPKO HEALTH INC 0.0%
Value $3.675M Shares 2,500,000 Share Price $1.47 Est. Cost/Share — Unrealized @ Report Date —
— BROADMARK RLTY CAP INC 0.0%
Value $2.726M Shares 7,174,613 Share Price $0.38 Est. Cost/Share — Unrealized @ Report Date —
— ZAFGEN INC 0.0%
Value $2.007M Shares 1,808,360 Share Price $1.11 Est. Cost/Share — Unrealized @ Report Date —
— APTINYX INC 0.0%
Value $1.397M Shares 408,549 Share Price $3.42 Est. Cost/Share — Unrealized @ Report Date —
— CYCLERION THERAPEUTICS INC 0.0%
Value $952K Shares 350,000 Share Price $2.72 Est. Cost/Share — Unrealized @ Report Date —